Kalkulačka z Bio Protocol na Brazílsky real
Jednoducho preveďte Bio Protocol na Brazílsky real s našou kalkulačkou. Zoznámte sa s vývojom konverzie a hlavnými ekvivalentmi medzi BIO a BRL.
Konvertor kryptomien
Bio Protocol na BRL — Trhové dáta
Trhová kapitalizácia
R$343,81M
24h objem
R$108,66M
Maximálna ponuka
3,32B
Ponuka v obehu
3,32B
Typ
currency
Cena BIO/BRL - Bio Protocol/Euro
Cena Bio Protocol je rastie
Hodnota Bio Protocol je R$0,1623. To znamená, že na nákup 5 BIO budeš musieť zaplatiť R$0,8114. Naopak, s R$1,00 môžeš kúpiť celkom 6,16237314 BIO, zatiaľ čo R$50,00 by ti umožnilo uskutočniť nákup 308,11865698 BIO.
V posledných 7 dňoch cena Bio Protocol zvýšila o +7,28%. Zatiaľ čo v posledných 24 hodinách sa cena zmenila o +5,27%.
Konverzia BIO na BRL
| Množstvo | 04. 07. 2026 00:00 |
|---|---|
| 0.5 BIO | R$0,0811 |
| 1 BIO | R$0,1623 |
| 2 BIO | R$0,3246 |
| 5 BIO | R$0,8114 |
| 10 BIO | R$1,62 |
| 50 BIO | R$8,11 |
| 100 BIO | R$16,23 |
| 500 BIO | R$81,14 |
| 1000 BIO | R$162,28 |
Konverzia BRL na BIO
| Množstvo | 04. 07. 2026 00:00 |
|---|---|
| R$0,5000 | 0.08113757 BIO |
| R$1,00 | 0.16227515 BIO |
| R$2,00 | 0.32455029 BIO |
| R$5,00 | 0.81137573 BIO |
| R$10,00 | 1.62275146 BIO |
| R$50,00 | 8.11375729 BIO |
| R$100,00 | 16.22751459 BIO |
| R$500,00 | 81.13757293 BIO |
| R$1.000,00 | 162.27514585 BIO |
Kúpte Bio Protocol bezpečne
Zaregistrujte sa na Bit2Me a získajte prístup k najspoľahlivejšej platforme na výmenu kryptomien na bezpečné nákupy a predaje Bio Protocol.
Čo je Bio Protocol?
Bio Protocol is a platform designed to accelerate scientific development through the decentralised funding and management of biotechnological projects. Its aim is to enable global communities of scientists, patients, and investors to collaborate on the creation and shared ownership of new drugs and therapies through decentralised autonomous organisations specialised in biotechnology, known as BioDAOs. The native token of Bio Protocol, called BIO, fulfils essential functions within the ecosystem. In addition to facilitating transactions, it grants its holders governance rights, allowing them to influence key decisions such as the selection of BioDAOs to support and the allocation of resources for the development of intellectual property assets. This approach seeks to democratise scientific research and encourage active community participation in biotechnological innovation.
